Imricor Medical Systems Stock Operating Margin
| IMR Stock | 1.16 0.06 5.45% |
Imricor Medical Systems fundamentals help investors to digest information that contributes to Imricor Medical's financial success or failures. It also enables traders to predict the movement of Imricor Stock. The fundamental analysis module provides a way to measure Imricor Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imricor Medical stock.
Imricor |
Imricor Medical Systems Company Operating Margin Analysis
Imricor Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Imricor Medical Operating Margin | (19.77) % |
Most of Imricor Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imricor Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Imricor Medical Systems has an Operating Margin of -19.7702%. This is 43.64% lower than that of the Health Care Equipment & Supplies sector and 49.71% lower than that of the Health Care industry. The operating margin for all Australia stocks is notably higher than that of the company.
Imricor Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imricor Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Imricor Medical could also be used in its relative valuation, which is a method of valuing Imricor Medical by comparing valuation metrics of similar companies.Imricor Medical is currently under evaluation in operating margin category among its peers.
Imricor Fundamentals
| Return On Equity | -2.75 | ||||
| Return On Asset | -1.25 | ||||
| Operating Margin | (19.77) % | ||||
| Current Valuation | 328.6 M | ||||
| Shares Outstanding | 270.18 M | ||||
| Shares Owned By Insiders | 20.26 % | ||||
| Shares Owned By Institutions | 14.56 % | ||||
| Price To Book | 3.97 X | ||||
| Price To Sales | 380.20 X | ||||
| Revenue | 615.57 K | ||||
| Gross Profit | (1.53 M) | ||||
| EBITDA | (21.87 M) | ||||
| Net Income | (34.09 M) | ||||
| Total Debt | 10.42 M | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (19.55 M) | ||||
| Earnings Per Share | (0.17) X | ||||
| Target Price | 0.71 | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 313.4 M | ||||
| Total Asset | 8.31 M | ||||
| Retained Earnings | (165 M) | ||||
| Working Capital | (628.21 K) | ||||
| Net Asset | 8.31 M |
About Imricor Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imricor Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imricor Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imricor Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imricor Stock Analysis
When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.